Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Certara Inc (CERT)

Certara Inc (CERT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,455,044
  • Shares Outstanding, K 159,679
  • Annual Sales, $ 243,530 K
  • Annual Income, $ -49,400 K
  • 60-Month Beta N/A
  • Price/Sales 18.69
  • Price/Cash Flow 2,414.13
  • Price/Book 4.62
Trade CERT with:

Options Overview Details

View History
  • Implied Volatility 70.38%
  • Historical Volatility 67.28%
  • IV Percentile 40%
  • IV Rank 37.59%
  • IV High 104.05% on 05/04/21
  • IV Low 50.10% on 08/16/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 98
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.06
  • Number of Estimates 2
  • High Estimate 0.07
  • Low Estimate 0.06
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +116.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.62 +1.01%
on 11/24/21
45.48 -38.65%
on 11/04/21
-11.94 (-29.97%)
since 10/26/21
3-Month
27.62 +1.01%
on 11/24/21
45.48 -38.65%
on 11/04/21
-3.64 (-11.54%)
since 08/26/21

Most Recent Stories

More News
Certara Announces Closing of Public Offering of Common Stock

PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its...

CERT : 27.90 (-2.11%)
Certara Announces Pricing of Public Offering of Common Stock

PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its...

CERT : 27.90 (-2.11%)
Certara Announces Proposed Public Offering of Common Stock

PRINCETON, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed...

CERT : 27.90 (-2.11%)
Certara Reports Third Quarter 2021 Financial Results

Raises full year 2021 guidance, reflecting strong revenue growth and the acquisition of Pinnacle 21...

CERT : 27.90 (-2.11%)
Certara Appoints James E. Cashman III as Chairman of Board of Directors

High-tech CEO with decades of experience supports continued innovation and growth...

CERT : 27.90 (-2.11%)
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services

Pinnacle 21 Enterprise software expedites regulatory review of all study submission data...

CERT : 27.90 (-2.11%)
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category...

CERT : 27.90 (-2.11%)
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021

PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release...

CERT : 27.90 (-2.11%)
Market Slips for Third Day While Waiting for CPI

Market Slips for Third Day While Waiting for CPI

FLMN : 4.85 (-4.90%)
FULT : 16.20 (-5.32%)
LEVI : 27.20 (-3.51%)
CVLG : 26.82 (-1.61%)
CERT : 27.90 (-2.11%)
WSC : 38.85 (-2.36%)
NKE : 168.02 (-2.33%)
TRIP : 26.75 (-5.18%)
APP : 90.71 (-3.83%)
ENPH : 247.42 (-3.01%)
GDRX : 36.82 (-2.31%)
YY : 54.45 (-3.83%)
Certara 推出全新 Synchrogenix™ Writer 软件,加速监管审批流程

基于云计算的、经过验证的监管软件帮助实现患者叙述自动化并提高其质量...

CERT : 27.90 (-2.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.

See More

Key Turning Points

3rd Resistance Point 29.53
2nd Resistance Point 29.15
1st Resistance Point 28.52
Last Price 27.90
1st Support Level 27.52
2nd Support Level 27.14
3rd Support Level 26.51

See More

52-Week High 45.48
Fibonacci 61.8% 37.18
Fibonacci 50% 34.61
Fibonacci 38.2% 32.05
Last Price 27.90
52-Week Low 23.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar